7^th International Conference on
Plasmodium vivax Research (ICPvR)

Paris, June 26-28, 2019
Auditorium of CIS

Heat wave

Météo-France forecasts very high temperatures, up to 40 ° C day and 25° C night, and warns that it will be very hot part of the week in France.

Remember to hydrate yourself, clothe yourself lightly and limit your movements outside.

Water in adequate quantity available on-site.

More information : « Heat wave Recommendations »

Plasmodium vivax is now the predominant cause of malaria outside sub-Saharan Africa and is considered to be a key obstacle to malaria elimination.

The unique biology of Plasmodium vivax with features such as the latent hypnozoite stage and early gametocytogenesis makes it more difficult to control and eliminate than Plasmodium falciparum. The development of Plasmodium vivax-specific interventions is thus clearly a priority for the malaria elimination research agenda. Development of tools that will allow the program to accelerate towards Plasmodium vivax elimination requires a bench-to-bedside-to-public health approach that facilitates collaborative, interdisciplinary research.

The International Conferences on Plasmodium vivax Research (ICPVR) are the only global series of conferences dedicated entirely to research on Plasmodium vivax malaria. ICPVR 2019 will bring together 250-300 researchers working on diverse aspects of Plasmodium vivax research from basic cell and molecular biology to field epidemiology, vector and clinical studies.

The conference will serve as an excellent opportunity to review progress made in different areas of Plasmodium vivax research, define knowledge gaps and provide opportunities to researchers to explore collaborative research strategies to address them. Overall the goal of the meeting is to provide a platform that highlights work on Plasmodium vivax, which has often been neglected, but is extremely important in the fight to eliminate malaria.

On Tuesday 25th June, there will be two side meetings ahead of the International Conference on Plasmodium vivax Research (ICPVR) at Institut Pasteur in Paris.

09:00 - 12:00. Data analytics and modelling for Plasmodium vivax

13:30 - 16:30. The Potential Use of Serology in Malaria Elimination

The meetings will be held on campus at Institut Pasteur. Please contact michael.white@pasteur.fr if you would like to attend.

Supported by

Local committee

Chetan Chitnis, (Chair), Institut Pasteur, Paris, France

Benoît Gamain, Institut National de la Transfusion Sanguine (INTS), Paris, France

Catherine Lavazec, Institut Cochin, France

Didier Ménard, Institut Pasteur, Paris, France

Ivo Mueller, (Vice Chair), Institut Pasteur, Paris, France

Olivier Silvie, Sorbonne Université, France

Georges Snounou, CEA-Université Paris Sud 11, INSERM U1184, CNRS, Fontenay-Aux-Roses, France

Michael White, Institut Pasteur, Paris, France

International Advisory Committee

John Kevin Baird, Eijkman Oxford Clinical Research Unit, Jakarta, Indonesia

Jane Carlton, New York University, New York, United States

Chetan Chitnis, (Chair), Institut Pasteur, Paris, France

Hernando A Del Portillo, Barcelona Institute fro Global Health - ISGlobal, Badalona, Spain

Simon Draper, University of Oxford, United Kingdom

Ingrid Felger, Swiss Tropical and Public Health Institute, Basel, Switzerland

Dionicia Gamboa, Universidad Peruana Cayetano Heredia, Lima, Peru

Marcus Lacerda, FIOCRUZ-AM, Manaus, Brazil

Dominique Mazier, Sorbonne Université, Paris, France

Sebastian Mikolajczak, Novartis Institute of Tropical Diseases, Oakland, United States

Ivo Mueller, (Vice Chair), Institut Pasteur, Paris, France

Jetsumon Sattabangkot, Mahidol University, Bangkok, Thailand

Neena Valecha, National Institute of Malaria Research, New Delhi, India

Call for abstract

Click here to

submit your abstract

CONTINUE

Registration

Click here to

CONTINUE